Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Micro Doses, Macro Potential? Considerations for Microdosing Tirzepatide in Multi-Dose Pens
Obesity (Silver Spring, Md.), 2026
Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study
Diabetes, obesity & metabolism, 2026
Starvation ketosis following self-administered tirzepatide obtained via online services in a young woman later diagnosed with anorexia nervosa: a case report
Journal of eating disorders, 2026
Effects of Tirzepatide on Metabolic Parameters in Patients with Psoriasis and Obesity: 24-Week Real-World Study
Dermatology and therapy, 2026
Tirzepatide in type 1 diabetes: beyond mere weight loss
Expert review of clinical pharmacology, 2026
Risk Factors for Hypoglycemia in Type 2 Diabetes Mellitus Patients Using Once-Weekly Semaglutide: A Matched Case-Control Study
Therapeutics and clinical risk management, 2026;22:610579
CGM-derived postprandial glucose with IcoSema versus other insulin regimens: a post hoc analysis of COMBINE 1 and 3
EClinicalMedicine, 2026;96:103985
LL-37: Biological Mechanisms and Emerging Therapeutic Applications in Intestinal Disease
Immunity, inflammation and disease;14(5):e70451
Tirzepatide for weight and behavior management in a patient with Smith-Magenis syndrome
JCEM case reports, 2026;4(7):luag152
Comparative Positioning of Orforglipron Among Selected GLP-1 Receptor Agonist Benchmarks: A Narrative Review
Cureus, 2026;18(6):e110178
Ocular disorders during treatment with GLP-1 receptor agonists: a systematic review and meta-analysis of observational studies
Frontiers in pharmacology, 2026;17:1808359
Longitudinal 18F-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET) Findings in Korsakoff Syndrome After Rapid Weight Loss During Tirzepatide Therapy: A Case Report
Cureus, 2026;18(6):e110101
A systematic review of semaglutide-associated kidney injury case reports
Frontiers in medicine, 2026;13:1793349
Glucagon-like peptide-1 receptor agonists as a metabolic optimization strategy in surgical prehabilitation: a translational perspective
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2026
Glucagonlike Peptide-1 (GLP-1) Receptor Agonists for Cardiometabolic Risk in Severe Mental Illness: A Narrative Review
Cureus, 2026;18(6):e110038
GLP-1RA- and Incretin-Based Therapies Within Lifestyle Interventions for Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis
Nutrients, 2026;18(11)
Prescribing of GLP-1 and GIP/GLP-1 Receptor Agonists and Other Glucose-Lowering Drugs Requiring Special Caution in Elderly Japanese People With Type 2 Diabetes: A Preliminary Report
Journal of clinical medicine research, 2026;18(5):292-300
Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions-A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
Pharmaceuticals (Basel, Switzerland), 2026;19(6)
Impact of Semaglutide on Hippocampal Injury in a Streptozotocin-Induced Model of Alzheimer’s Disease
Biomedicines, 2026;14(6)
Incretin-Based Therapies in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF): A Systematic Review of Emerging Cardiometabolic Disease Modification Beyond Glycemic Control
Cureus, 2026;18(5):e109953